IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
Novel MOG assay aids diagnosis of demyelinating diseases - Mayo Clinic
IJMS | Free Full-Text | Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders
Review of literature on anti-MOG antibodies in adult NMO/NMOSD | Download Table
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Myelitis Presenting with Headache | Canadian Journal of Neurological Sciences | Cambridge Core
Anti-MOG Antibody Test Identifies Atypical Features, Prognosis in MS - Neurology Advisor
MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation | SpringerLink
MOG antibody demyelination | Great Ormond Street Hospital
Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder - Caspian Journal of Neurological Sciences
MSParis2017: MOG-associated Demyelination Can Be Treated with Steroids
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Test in Delhi, NCR | GDIC